We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+5.99%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.75B
AUM Growth
-$39.4M
Cap. Flow
-$856M
Cap. Flow %
-14.88%
Top 10 Hldgs %
22.09%
Holding
798
New
336
Increased
102
Reduced
128
Closed
170
Avg Time Held Equity + Options
1.1 quarters
Top 10 Avg Time Held Equity + Options
1.6 quarters
Top 20 Avg Time Held Equity + Options
1.5 quarters
Avg Time Held Equity only
1.1 quarters
Top 10 Avg Time Held Equity only
1.6 quarters
Top 20 Avg Time Held Equity only
1.5 quarters

Top Buys

Rank Stock Value
1
CFN
CAREFUSION CORPORATION
CFN
+$125M
2
CVD
COVANCE INC.
CVD
+$75.9M
3
AGN
Allergan Inc
AGN
+$71.6M
4
SIAL
SIGMA - ALDRICH CORP
SIAL
+$69.7M
5
PEP icon
PepsiCo
PEP
+$52.7M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$72.3M
2
VYX icon
NCR Voyix
VYX
+$64.1M
3
HUM icon
Humana
HUM
+$64M
4
CNQR
CONCUR TECHNOLOGIES INC
CNQR
+$63.4M
5
TSM icon
TSMC
TSM
+$62.3M

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.33%
2 Consumer Discretionary 12.63%
3 Healthcare 11.94%
4 Industrials 11.3%
5 Consumer Staples 10.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ORBC
301
DELISTED
ORBCOMM, Inc.
ORBC
$1.14M 0.02%
+175,000
New +$1.1M
2014 Q4
0 quarters
PBR.A icon
302
Petrobras Class A
PBR.A
$146B
$1.14M 0.02%
+150,000
New +$1.69M
2014 Q4
0 quarters
XENT
303
DELISTED
Intersect ENT, Inc
XENT
$1.13M 0.02%
+60,759
New +$1.09M
2014 Q4
0 quarters
TXMD icon
304
TherapeuticsMD
TXMD
$23.4M
$1.11M 0.02%
5,000
+500
+11% +$103K
2014 Q1
3 quarters
WLL
305
DELISTED
Whiting Petroleum Corporation
WLL
$1.11M 0.02%
112
-110
-50% -$1.68M
2014 Q3
1 quarter
RARE icon
306
Ultragenyx Pharmaceutical
RARE
$1.51B
$1.1M 0.02%
+25,000
New +$1.15M
2014 Q4
0 quarters
MJN
307
DELISTED
Mead Johnson Nutrition Company
MJN
$1.09M 0.02%
10,801
-47,622
-82% -$4.75M
2014 Q3
1 quarter
KITE
308
DELISTED
Kite Pharma, Inc.
KITE
$1.06M 0.02%
+18,445
New +$777K
2014 Q4
0 quarters
EVFM
309
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$1.04M 0.02%
+1,551
New +$1.17M
2014 Q4
0 quarters
BLCM
310
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$1.04M 0.02%
+4,524
New +$970K
2014 Q4
0 quarters
CHD icon
311
Church & Dwight Co
CHD
$23.7B
$946K 0.02%
24,000
-69,600
-74% -$2.57M
2014 Q3
1 quarter
GCVRZ
312
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$944K 0.02%
1,203,178
– –
2013 Q2
6 quarters
CLX icon
313
Clorox
CLX
$10.2B
$938K 0.02%
+9,000
New +$900K
2014 Q4
0 quarters
SPLK icon
314
DELISTED
Splunk Inc
SPLK
$884K 0.02%
+15,000
New +$921K
2014 Q4
0 quarters
HUBG icon
315
HUB Group
HUBG
$1.63B
$882K 0.02%
46,302
-825,462
-95% -$15.3M
2014 Q3
1 quarter
EDR icon
316
DELISTED
Education Realty Trust Inc
EDR
$880K 0.02%
24,054
-11,304
-32% -$387K
2013 Q3
5 quarters
ED icon
317
Consolidated Edison
ED
$39.6B
$871K 0.02%
13,199
+7,432
+129% +$466K
2014 Q3
1 quarter
TV icon
318
Televisa
TV
$1.18B
$852K 0.01%
25,000
-6,200
-20% -$215K
2014 Q3
1 quarter
CCEP icon
319
CALL
Coca-Cola Europacific Partners
CCEP
$46.2B
$835K 0.01%
402,200
+202,200
+101% +$8.72M
2014 Q3
1 quarter
EIDO icon
320
iShares MSCI Indonesia ETF
EIDO
$399M
$823K 0.01%
+30,000
New +$810K
2014 Q4
0 quarters
GEO icon
321
The GEO Group
GEO
$4.18B
$797K 0.01%
29,607
+20,098
+211% +$524K
2014 Q3
1 quarter
INGR icon
322
Ingredion
INGR
$6.07B
$781K 0.01%
+9,201
New +$732K
2014 Q4
0 quarters
BG icon
323
Bunge Global
BG
$20B
$770K 0.01%
+8,475
New +$746K
2014 Q4
0 quarters
FTNT icon
324
Fortinet
FTNT
$142B
$766K 0.01%
+125,000
New +$674K
2014 Q4
0 quarters
SPG icon
325
Simon Property Group
SPG
$65.2B
$763K 0.01%
4,191
-2,737
-40% -$486K
2014 Q3
1 quarter
11 12
13
14 15

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q4 2014 Portfolio in Review

As of Q4 2014, UBS O'Connor held 798 positions worth $5.75B, down 0.68% from $5.79B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

UBS O'Connor withdrew a net $856M in Q4 2014, closing 170 positions and reducing 128 holdings. Its most notable exit was NCR Voyix, an estimated $64.1M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, UBS O'Connor opened a new position in CAREFUSION CORPORATION worth $129M.

  • UBS O'Connor's largest Q4 2014 buy was CAREFUSION CORPORATION: 2,168,433 shares worth $129M.
  • UBS O'Connor added most to Allergan Inc in Q4 2014, an estimated $71.6M increase.
  • UBS O'Connor's biggest Q4 2014 reduction was Alibaba, cutting an estimated $72.3M.
  • UBS O'Connor fully exited NCR Voyix in Q4 2014, selling an estimated $64.1M.
  • UBS O'Connor's ten largest holdings make up 22% of its $5.75B portfolio in Q4 2014.
  • UBS O'Connor opened 336 new positions and closed 170 in Q4 2014.
  • UBS O'Connor's portfolio value fell 0.68% quarter-over-quarter to $5.75B.

Based on UBS O'Connor's 13F filing for Q4 2014, filed 13 Feb 2015.